Gennex Laboratories [GENNEX] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Gennex Laboratories Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Gennex Laboratories Ltd. wins in 5 metrics, Sun Pharmaceutical Industries Ltd. wins in 14 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Gennex Laboratories Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 14.37 36.73 Gennex Laboratories Ltd.
Price-to-Book Ratio 1.19 5.15 Gennex Laboratories Ltd.
Debt-to-Equity Ratio 39.79 6.68 Sun Pharmaceutical Industries Ltd.
PEG Ratio -7.90 3.59 Sun Pharmaceutical Industries Ltd.
EV/EBITDA 16.60 23.61 Gennex Laboratories Ltd.
Profit Margin (TTM) 12.59% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 13.54% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 13.54% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 9.31% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) 7.08% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $-197.44M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield N/A 0.97% N/A
1-Year Return -15.32% 7.25% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 1.68 7.05 Gennex Laboratories Ltd.
Enterprise Value $3.08B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 2.03 6.66 Gennex Laboratories Ltd.
Gross Profit Margin (TTM) 29.90% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $6 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $0.73 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) 0.60 0.11 Sun Pharmaceutical Industries Ltd.

Gennex Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

GENNEX
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Gennex Laboratories Ltd.-1.42%-5.86%9.27%3.17%-21.03%-24.98%
Sun Pharmaceutical Industries Ltd.-0.08%-3.03%-1.92%2.17%-1.01%3.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Gennex Laboratories Ltd.-15.32%75.15%88.92%58.41%864.75%897.46%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Gennex Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricGENNEXSUNPHARMA
Market Information
Market Cap i₹2.50B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i401,7723,903,142
90 Day Avg. Volume i626,7923,253,866
Last Close₹11.08₹1,788.50
52 Week Range₹7.05 - ₹17.25₹1,548.00 - ₹1,916.60
% from 52W High-35.77%-6.68%
All-Time High₹29.00 (Sep 16, 2024)₹1,960.35 (Sep 30, 2024)
% from All-Time High-61.79%-8.77%
Growth Metrics
Quarterly Revenue Growth0.07%0.14%
Quarterly Earnings Growth0.13%0.16%
Financial Health
Profit Margin (TTM) i0.13%0.19%
Operating Margin (TTM) i0.14%0.26%
Return on Equity (TTM) i0.09%0.15%
Debt to Equity (MRQ) i39.796.68
Cash & Liquidity
Book Value per Share (MRQ)₹8.78₹324.46
Cash per Share (MRQ)₹1.98₹115.87
Operating Cash Flow (TTM) i₹-75,467,000₹110.84B
Levered Free Cash Flow (TTM) i₹181.23M₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend i₹0.00₹16.50

Valuation & Enterprise Metrics Analysis: Gennex Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricGENNEX (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i14.3736.73
Forward P/E iN/A29.48
PEG Ratio i-7.903.59
Price to Sales (TTM) i1.687.05
Price to Book (MRQ) i1.195.15
Market Capitalization
Market Capitalization i₹2.50B₹3.88T
Enterprise Value i₹3.08B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i2.036.66
Enterprise to EBITDA i16.6023.61
Risk & Other Metrics
Beta i0.600.11
Book Value per Share (MRQ) i₹8.78₹324.46

Financial Statements Comparison: Gennex Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGENNEX (2025)SUNPHARMA (2025)
Revenue/Sales i1.38B520.41B
Cost of Goods Sold i982.23M121.98B
COGS % of Revenue i71.4%23.4%
Gross Profit i393.29M398.44B
Gross Margin i28.6%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i147.25M125.81B
Operating Margin i10.7%24.2%
EBITDA i271.66M167.25B
EBITDA Margin i19.7%32.1%
Pre-Tax Income i215.47M137.52B
Pre-Tax Income % of Revenue i15.7%26.4%
Income Tax i32.75M27.72B
Income Tax % of Revenue i2.4%5.3%
Net Income (Profit) i181.23M109.65B
Profit Margin i13.2%21.1%

Balance Sheet & Liquidity Metrics

MetricGENNEX (2025)SUNPHARMA (2025)
Cash & Equivalents i545.89M102.69B
Total Current Assets i1.81B526.24B
Total Current Assets % of Revenue i131.7%101.1%
Total Current Liabilities i445.55M181.94B
Total Current Liabilities % of Revenue i32.4%35.0%
Long-Term Debt i168.93M3.58B
Long-Term Debt % of Revenue i12.3%0.7%
Total Shareholders Equity i1.95B724.86B
Retained Earnings i562.59M578.62B
Retained Earnings % of Revenue i40.9%111.2%
Property, Plant & Equipment i88.69M100.36B

Cash Flow Statement Comparison

MetricGENNEX (2025)SUNPHARMA (2025)
Operating Cash Flow i-75.47M110.84B
Operating Cash Flow % of Revenue i-5.5%21.3%
Capital Expenditures i-87.47M-20.68B
Free Cash Flow i-197.44M119.44B
FCF Margin i-14.4%23.0%
Debt Repayment iN/A-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricGENNEXSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i242.95M2.40B
Float Shares i156.62M1.07B
% Held by Insiders i33.66%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i66.34%15.69%

Dividend Analysis & Yield Comparison: Gennex Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricGENNEXSUNPHARMA
Last 12-Month Dividend i₹0.00₹16.50
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend i₹0.00₹17.33
3-Year Avg Dividend Yield iN/A0.51%
3-Year Total Dividends i₹0.00₹52.00
Ex-Dividend DateN/AFeb 05, 2026